Merck inks $2 B agreement with Hengrui Pharma for cardiovascular drug

Merck, known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., a global pharmaceu...

March 27, 2025 | Thursday | News
China's Bio-Thera inks biosimilar deal with India-based Dr. Reddy’s for Southeast Asia region

Bio-Thera Solutions, a China-based biopharmaceutical company developing a pipeline of innovative therapies and biosimila...

March 26, 2025 | Wednesday | News
United Laboratories and Novo Nordisk ink $2 B deal for treatment of obesity, diabetes and others

China based The United Laboratories International Holdings Limited (TUL) and Danish pharmaceutical company Novo Nordisk ...

March 25, 2025 | Tuesday | News
AstraZeneca announces investment of $2.5 B to establish sixth global strategic R&D centre in China

British pharmaceutical company AstraZeneca has announced an investment of $2.5 billion in Beijing to establish its sixth...

March 24, 2025 | Monday | News
BenQ Medical Technology and Brain Navi align partnership to advance neurosurgical robotics in China

Taiwan-based startup Brain Navi Biotechnology, a leading innovator in neurosurgical robotics, has announced a strategic ...

March 20, 2025 | Thursday | News
PolyU plans to establish Hong Kong’s third medical school

The Hong Kong Polytechnic University (PolyU) has submitted a proposal to the Hong Kong Special Administrative Region (HK...

March 21, 2025 | Friday | News
Harbour BioMed launches Élancé Therapeutics to advance next-gen obesity therapies

China & US based Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and...

March 17, 2025 | Monday | News
Teva enhances pharma distribution system in China

Teva Hong Kong has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network (KLN)....

March 14, 2025 | Friday | News
Insilico Medicine secures $110 M Series E financing to advance AI-driven drug discovery innovation

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfu...

March 13, 2025 | Thursday | News
WuXi XDC and AbTis announce strategic partnership to advance next-generation ADCs

WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialisi...

March 11, 2025 | Tuesday | News
Report reveals high RSV-associated hospitalisation costs in Hong Kong & Singapore

A newly released white paper, based on research conducted independently by IQVIA, a global healthcare consultancy, ...

March 11, 2025 | Tuesday | News
Indaptus Therapeutics extends patent portfolio in China, Japan, and Israel

US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...

March 7, 2025 | Friday | News
China Bans Illumina, Deepening U.S.-China Trade Rift and Reshaping Global Biotech

  Amid intensifying U.S.-China trade tensions, Beijing has escalated its retaliatory measures by banning U.S. biot...

March 5, 2025 | Wednesday | Analysis
Boehringer Ingelheim enhances biopharmaceutical contract manufacturing services in China

Boehringer Ingelheim’s biopharmaceutical facility in Shanghai, China, meets the conditions to participate in a reg...

March 5, 2025 | Wednesday | News
WuXi Biologics introduces new platform to boost recombinant protein and plasmid DNA production

China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...

March 4, 2025 | Tuesday | News
WuXi Biologics Successfully Passes Japan PMDA GMP Inspection Again

WuXi Biologics, a leading global contract research, development, and manufacturing organization (CRDMO...

February 28, 2025 | Friday | News
Eisai grants exclusive development and distribution rights for Tasurgratinib in Greater China to SciClone Pharma

Japan-headquartered pharmaceutical firm Eisai has entered into an exclusive license agreement with a subsidiary of SciCl...

February 28, 2025 | Friday | News
GE HealthCare names new president and CEO for China biz

GE HealthCare (GEHC), a leading global healthcare solutions provider, has announced that Yihao Zhang, president and Chie...

February 27, 2025 | Thursday | News